News and reflections from the world of AI

    Validation of PD-L1 AI model launches in six labs across the Netherlands

    Introduction  Programmed death-ligand 1 (PDL1) is a protein that, when attached to T cells, prevent the immune system from killing cancer cells. ...
    Written by Aiforia

    Interview with Dr. Rish Pai on using AI to study colorectal cancer

    Introduction Colorectal cancer is the third most common cancer in the United States and pathologists are becoming increasingly valuable in the ...
    Written by Aiforia

    The impact of digital pathology on immuno-oncology

    Immuno-oncology (IO) relies on harnessing our own immune systems in order to develop personalized therapies and medications for cancer. For this, a ...
    Written by Aiforia
    January 7, 2021

    Leiden University Medical Center case study: AI-driven PD-L1 scoring in lung cancer

    Describe your project with Aiforia. Liesbeth: We created an AI model, a deep learning algorithm, for PD-L1 scoring in NSCLC histology earlier and are now aiming to validate this AI model in other laboratory workups as well, including different antibodies and scanners. We will describe the steps that are needed for adapting an existing AI model to a new, local laboratory workup (domain ...
    Written by Aiforia
    October 15, 2020

    PD-L1 case study: interview with Liesbeth Hondelink

    “When I first started, I did not know anything about AI,” describes Liesbeth Hondelink, MSc student at Leiden University Medical Centre in the Netherlands, when she applied to the aiForward program. Her research focuses on PD-L1, a protein which has gained much popularity in a field that has been under the spotlight for some time now: cancer immunotherapy. Liesbeth and her lab are specifically ...
    Written by Aiforia
    September 1, 2020

    MIT case study: advancing lung cancer research with AI

    Aiforia is helping advance cancer research at MIT
    Written by Aiforia
    1 2